Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: TheStreet.com Ratings
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Shire Plc to acquire Lumena Pharmaceuticals


Monday, 12 May 2014 07:00am EDT 

Shire Plc:Acquisition of Lumena Pharmaceuticals, biopharmaceutical co with late stage rare disease pipeline assets.Will acquire Lumena Pharmaceuticals for an upfront payment of $260 mln in cash, plus payment for net cash at closing, and near-term contingent milestone payments related to ongoing clinical trials. 

Company Quote

252.67
-0.27 -0.11%
25 Jul 2014